Testing effectiveness (Phase 2)Study completedNCT05424276
What this trial is testing
A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's Disease
Who this might be right for
Parkinson Disease
ABLi Therapeutics, Inc. 137